Sincalide, also known as cholecystokinin octapeptide (CCK-8), is a hormone used to diagnose and treat certain types of gallbladder disorders. It is a synthetic form of cholecystokinin, a hormone produced in the small intestine that helps control digestion. Sincalide is injected intravenously and works by stimulating the contraction of the gallbladder, which allows for the visualization of the gallbladder and its contents (e.g. gallstones) when undergoing an imaging test. Sincalide may also be used to diagnose pancreatic disorders or to assess the functioning of the gallbladder and pancreas.
I previously described the medical substance Sincalide on Tuesday, 19 March 2024 at 12:55 IST. Here's that information again:
Sincalide is a medication used as a diagnostic tool in imaging tests of the digestive system, particularly the gallbladder and pancreas.
Key points:
- Function: Not a treatment, but a cholecystokinetic agent to stimulate the gallbladder and pancreas during imaging tests [1, 2, 3].
- Purpose: Helps assess gallbladder and pancreatic function by causing contraction and secretion for better visualization in procedures like cholecystography or ultrasonography [1, 2].
- Mechanism: Mimics a natural hormone (cholecystokinin) that stimulates these organs [1, 2].
- Administration: Intravenous (IV) injection before imaging [2, 3].
- Considerations: Generally well-tolerated but can cause side effects like abdominal discomfort, nausea, flushing [2, 3]. Inform your doctor about allergies or medical conditions before receiving it, as it might not be suitable for everyone [2]. It's a prescription medication [2].
- Alternatives: Other imaging techniques like MRCP might be used in some cases [4].